144 related articles for article (PubMed ID: 28748604)
1. Implementing pharmacogenomics in modern health care: The 2017 scientific meeting of the Human Genome Variation Society.
Lanting P; Oetting WS
Hum Mutat; 2017 Nov; 38(11):1606-1610. PubMed ID: 28748604
[No Abstract] [Full Text] [Related]
2. The role of pharmacogenetics and pharmacogenomics in 21st-century medicine: state of the art and new challenges discussed in the VII Conference of the Spanish Pharmacogenetics and Pharmacogenomics Society (SEFF).
Rodriguez-Antona C
Drug Metab Pers Ther; 2016 Mar; 31(1):1-2. PubMed ID: 26641977
[No Abstract] [Full Text] [Related]
3. The Promise of Pharmacogenomics: Genetic variation can be used to individualize drug therapy, and is an integral component of genomic medicine.
Am J Med Genet A; 2019 Dec; 179(12):2324-2325. PubMed ID: 31709748
[No Abstract] [Full Text] [Related]
4. New perspectives in personalised medicine for ethnicity in cancer: population pharmacogenomics and pharmacometrics.
Nair S; LLerena A
Drug Metab Pers Ther; 2018 Jun; 33(2):61-64. PubMed ID: 29688886
[No Abstract] [Full Text] [Related]
5. Are Randomized Controlled Trials Necessary to Establish the Value of Implementing Pharmacogenomics in the Clinic?
Huddart R; Sangkuhl K; Whirl-Carrillo M; Klein TE
Clin Pharmacol Ther; 2019 Aug; 106(2):284-286. PubMed ID: 30977517
[No Abstract] [Full Text] [Related]
6. [Personalised medicine].
Broich K; Bieber T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1465-7. PubMed ID: 24170074
[No Abstract] [Full Text] [Related]
7. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine.
Schwartz EJ; Issa AM
Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827
[TBL] [Abstract][Full Text] [Related]
8. Implementation of wide-scale pharmacogenetic testing in primary care.
Natasha Petry ; Baye J; Aifaoui A; Wilke RA; Lupu RA; Savageau J; Gapp B; Massmann A; Hahn D; Hajek C; Schultz A
Pharmacogenomics; 2019 Aug; 20(12):903-913. PubMed ID: 31453774
[TBL] [Abstract][Full Text] [Related]
9. Significance of Pharmacogenetics and Pharmacogenomics Research in Current Medical Practice.
Prakash S; Agrawal S
Curr Drug Metab; 2016; 17(9):862-876. PubMed ID: 27494310
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
Nguyen TT; Pearson RA; Mohamed ME; Schladt DP; Berglund D; Rivers Z; Skaar DJ; Wu B; Guan W; van Setten J; Keating BJ; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
J Clin Pharm Ther; 2020 Dec; 45(6):1457-1465. PubMed ID: 32662547
[TBL] [Abstract][Full Text] [Related]
11. [Personalised medicine. Aims and challenges].
Bieber T; Broich K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1468-72. PubMed ID: 24170075
[TBL] [Abstract][Full Text] [Related]
12. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
Reiss SM;
J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics signature: A novel strategy on the individual differences in drug response.
Guo C; Lin X; Yin J; Xie X; Li J; Meng X; Wu J; Huang L; Huang Z; Yang G; Zhou H; Chen X
Cancer Lett; 2018 Apr; 420():190-194. PubMed ID: 29432844
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics.
Roden DM; McLeod HL; Relling MV; Williams MS; Mensah GA; Peterson JF; Van Driest SL
Lancet; 2019 Aug; 394(10197):521-532. PubMed ID: 31395440
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.
Vo TT; Bell GC; Owusu Obeng A; Hicks JK; Dunnenberger HM
Pharmacotherapy; 2017 Sep; 37(9):1014-1022. PubMed ID: 28699700
[TBL] [Abstract][Full Text] [Related]
16. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review).
Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M
Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205
[TBL] [Abstract][Full Text] [Related]
17. 6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy.
Stojiljkovic M; Fazlagic A; Dokmanovic-Krivokapic L; Nikcevic G; Patrinos GP; Pavlovic S; Zukic B
Hum Genomics; 2012 Sep; 6(1):19. PubMed ID: 23157848
[TBL] [Abstract][Full Text] [Related]
18. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
[TBL] [Abstract][Full Text] [Related]
19. The challenges of implementing pharmacogenomic testing in the clinic.
Moyer AM; Caraballo PJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
[TBL] [Abstract][Full Text] [Related]
20. Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities.
Chenoweth MJ; Giacomini KM; Pirmohamed M; Hill SL; van Schaik RHN; Schwab M; Shuldiner AR; Relling MV; Tyndale RF
Clin Pharmacol Ther; 2020 Jan; 107(1):57-61. PubMed ID: 31696505
[No Abstract] [Full Text] [Related]
[Next] [New Search]
